Literature DB >> 3161561

Hypoplastic anemia in B cell chronic lymphocytic leukemia: evolution of T cell-mediated suppression of erythropoiesis in early-stage and late-stage disease.

K F Mangan, L D'Alessandro.   

Abstract

To define further the role of marrow T suppressor lymphocytes in the pathogenesis of the hypoproliferative anemia in all Rai clinical stages of B cell chronic lymphocytic leukemia (CLL), marrow erythroid progenitor cell (CFU-E and BFU-E) frequency, marrow T gamma lymphocyte frequency per 1,000 nucleated marrow cells, and T cell-erythroid progenitor cell interactions were examined in 30 CLL patients and normal control subjects. As compared with control subjects, decreased numbers of CFU-E and BFU-E were found in patient marrow depleted of neoplastic B cells in all Rai stages of the disease. As a group, Rai stage III through IV patients with or without aplasia (CLL-aplasia) had significantly fewer CFU-E and BFU-E than did Rai O through II stage patients. The numbers of T gamma cells infiltrating CLL marrows were increased 3, 9, and 20 times normal in Rai O through II, Rai III through IV, and CLL-aplasia groups, respectively. Removal of T cells from marrow increased growth of CFU-E and BFU-E in all Rai O through IV patients, but the increase was significant in the CLL-aplasia group only (P less than .05). However, autologous coculture of marrow T cells or T gamma cells but not B cells with marrow B + T-depleted null cells at ratios of 0.2:1 to 1:1 suppressed CFU-E and BFU-E growth in all three patient groups. We conclude that the hypoproliferative anemia occurring in the course of B cell CLL is due to gradual accumulation in the marrow of T gamma lymphocytes which suppress erythroid progenitor cell growth. T gamma cell suppression of erythropoiesis and marrow T gamma cell expansion is detectable in the earliest Rai stages of the disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161561

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Autoimmunity in chronic lymphocytic leukaemia.

Authors:  T J Hamblin; D G Oscier; B J Young
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

2.  Serum erythropoietic inhibitors in patients with pure red cell aplasia.

Authors:  M Takahashi; K Nikkuni; I Tanaka; T Furukawa; Y Moriyama; A Shibata; S Satoh; Y Kuwabara; Y Maruyama; Y Matsunaga
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

Review 3.  Autoimmune cytopenias in chronic lymphocytic leukemia.

Authors:  Giovanni D'Arena; Roberto Guariglia; Francesco La Rocca; Stefania Trino; Valentina Condelli; Laura De Martino; Vincenzo De Feo; Pellegrino Musto
Journal:  Clin Dev Immunol       Date:  2013-04-16

Review 4.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.